Kaken Pharmaceutical Co., Ltd.
4521.T
#6410
Rank
โ‚น88.33 B
Marketcap
โ‚น2,333
Share price
2.05%
Change (1 day)
5.94%
Change (1 year)

Revenue for Kaken Pharmaceutical Co., Ltd. (4521.T)

Revenue in 2023: โ‚น42.30 Billion

According to Kaken Pharmaceutical Co., Ltd.'s latest financial reports the company's current revenue (TTM ) is โ‚น47.07 Billion. In 2023 the company made a revenue of โ‚น42.30 Billion a decrease over the revenue in the year 2022 that were of โ‚น46.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kaken Pharmaceutical Co., Ltd. from 2009 to 2023

Annual revenue

Year Revenue Change
2023โ‚น42.30 B-8.13%
2022โ‚น46.04 B-8.24%
2021โ‚น50.18 B-4.55%
2020โ‚น52.57 B-12.39%
2019โ‚น60.01 B0.58%
2018โ‚น59.66 B4.96%
2017โ‚น56.84 B-12.02%
2016โ‚น64.61 B8.48%
2015โ‚น59.55 B9.6%
2014โ‚น54.33 B0.08%
2013โ‚น54.29 B-7.49%
2012โ‚น58.69 B0.35%
2011โ‚น58.48 B31.92%
2010โ‚น44.33 B6.16%
2009โ‚น41.76 B